Examining the impacts of the covid-19 pandemic on library makerspaces and LIS makerspace curricula

The paper will outline two synergistic analyses that engage with the themes of resilient futures and education: a case study on the pandemic’s impact on LIS makerspace course curricula that was quickly converted from face-to-face to remote learning, and a broader analysis that explores how makerspace information professionals in higher education have adapted their services in response to safety protocols and to the holistic needs of their user communities. This paper contributes both to the conversation of LIS curricula as it pertains to teaching and training upcoming information professionals for careers in makerspaces, while also contextualizing these adaptations within the larger changes that were implemented by academic library makerspaces in North Carolina

Social Media Representations of Makerspaces

Libraries across the world have increasingly established makerspaces and incorporated making-related activities into their programming. Yet little is known about how this proliferation translates digitally. In response, this study uncovers how libraries construct virtual representations of makers and makerspaces through their social media content and the evolution of content across time. This research analyzed 36,756 social media posts created between 2012-2021 and identifies statistically significant changes in quantitative metrics, uncovers the themes present in posts, and describes the identities and topics featured. Revealing these digital representations of makers and making is important because this content can replicate oppressive structures by influencing who uses these spaces and what is created

Survey of critical wetlands and riparian areas in Archuleta County

Prepared for: Colorado Dept. of Natural Resources, Division of Wildlife, Wetlands Program.Includes bibliographical references

Effects of warm climatic periods on dairy cow behaviour and production in Scotland

Global warming is resulting in an overall increase in temperatures and in the frequency of extreme weather events. In dairy cattle, thresholds within the temperature-humidity index (THI) have been used to indicate points at which cattle will likely experience thermal stress (e.g., a THI threshold of 75 predicts thermal stress). However, high-yielding dairy cows that reside in temperate maritime climates may experience some degree of thermal discomfort below this threshold particularly when they are housed. Housing often results in high levels of humidity. The use of technology such as activity monitors and automated intake measures allow us to monitor responses. The aim of this study was to use technological solutions to assess behavioural changes in response to moderate increases in THI levels. Data from dairy cattle on an experimental unit were used. Data on daily lying times, lying bout frequency, step count, feed and water intake and milk yield were extracted for 8 pairs of warmer (THI<65) and 8 matching cooler (THI=43 to 60) periods. Warm and cool periods were no more than 5 weeks apart to ensure that the data from the same animals were being compared. The first three days from each period were analysed. Results showed that total daily lying time was shorter during warmer periods than cooler periods (P<0.05; means and SEMs (h): warm: 11.3±0.06h; cool: 11.8±0.06h). However, there was no effect of THI level on the no. of steps taken by cows (P>0.05 (counts) warm: 868±8 steps; cool: 878±9 steps). Water intake was higher during warm periods (P<0.05: (l) = warm: 81.2±0.7l; cool: 72.1±0.6), but there was no difference in feed intake (warm: 57.6±0.5kg; cool: 57.1±0.3kg). Milk yield was lower during warm periods than cool periods (P<0.05; (l): warm: 31.8±0.3; cool: 32.7±0.2). This suggests that behaviour and milk yield are mildly adversely affected even in conditions that are not traditionally regarded as exceeding cows’ ability to cope with thermal challenge

Effects of warm climatic periods on dairy cow behaviour and production in Scotland

Global warming is resulting in an overall increase in temperatures and in the frequency of extreme weather events. In dairy cattle, thresholds within the temperature-humidity index (THI) have been used to indicate points at which cattle will likely experience thermal stress (e.g., a THI threshold of 75 predicts thermal stress). However, high-yielding dairy cows that reside in temperate maritime climates may experience some degree of thermal discomfort below this threshold particularly when they are housed. Housing often results in high levels of humidity. The use of technology such as activity monitors and automated intake measures allow us to monitor responses. The aim of this study was to use technological solutions to assess behavioural changes in response to moderate increases in THI levels. Data from dairy cattle on an experimental unit were used. Data on daily lying times, lying bout frequency, step count, feed and water intake and milk yield were extracted for 8 pairs of warmer (THI<65) and 8 matching cooler (THI=43 to 60) periods. Warm and cool periods were no more than 5 weeks apart to ensure that the data from the same animals were being compared. The first three days from each period were analysed. Results showed that total daily lying time was shorter during warmer periods than cooler periods (P<0.05; means and SEMs (h): warm: 11.3±0.06h; cool: 11.8±0.06h). However, there was no effect of THI level on the no. of steps taken by cows (P>0.05 (counts) warm: 868±8 steps; cool: 878±9 steps). Water intake was higher during warm periods (P<0.05: (l) = warm: 81.2±0.7l; cool: 72.1±0.6), but there was no difference in feed intake (warm: 57.6±0.5kg; cool: 57.1±0.3kg). Milk yield was lower during warm periods than cool periods (P<0.05; (l): warm: 31.8±0.3; cool: 32.7±0.2). This suggests that behaviour and milk yield are mildly adversely affected even in conditions that are not traditionally regarded as exceeding cows’ ability to cope with thermal challenge

Survey of critical wetlands and riparian areas in La Plata County

Prepared for: Colorado Department of Natural Resources.May 2004.Includes bibliographical references

Assessment of critical biological resources, La Plata County, Colorado

Prepared for: La Plata County, Durango, Colorado.Includes bibliographical references

Narrative Exposure Therapy as a treatment for child war survivors with posttraumatic stress disorder: Two case reports and a pilot study in an African refugee settlement

BACKGROUND: Little data exists on the effectiveness of psychological interventions for children with posttraumatic stress disorder (PTSD) that has resulted from exposure to war or conflict-related violence, especially in non-industrialized countries. We created and evaluated the efficacy of KIDNET, a child-friendly version of Narrative Exposure Therapy (NET), as a short-term treatment for children. METHODS: Six Somali children suffering from PTSD aged 12–17 years resident in a refugee settlement in Uganda were treated with four to six individual sessions of KIDNET by expert clinicians. Symptoms of PTSD and depression were assessed pre-treatment, post-treatment and at nine months follow-up using the CIDI Sections K and E. RESULTS: Important symptom reduction was evident immediately after treatment and treatment outcomes were sustained at the 9-month follow-up. All patients completed therapy, reported functioning gains and could be helped to reconstruct their traumatic experiences into a narrative with the use of illustrative material. CONCLUSIONS: NET may be safe and effective to treat children with war related PTSD in the setting of refugee settlements in developing countries

Identifying flares in rheumatoid arthritis: Reliability and construct validation of the OMERACT RA Flare Core Domain Set

Objective: To evaluate the reliability of concurrent flare identification using 3 methods (patient, rheumatologist and Disease Activity Score (DAS)28 criteria), and construct validity of candidate items representing the Outcome Measures in Rheumatology Clinical Trials (OMERACT) RA Flare Core Domain Set. Methods: Candidate flare questions and legacy measures were administered at consecutive visits to Canadian Early Arthritis Cohort (CATCH) patients between November 2011 and November 2014. The American College of Rheumatology (ACR) core set indicators were recorded. Concordance to identify flares was assessed using the agreement coefficient. Construct validity of flare questions was examined: convergent (Spearman's r); discriminant (mean differences between flaring/non-flaring patients); and consequential (proportions with prior treatment reductions and intended therapeutic change postflare). Results: The 849 patients were 75% female, 81% white, 42% were in remission/low disease activity (R/LDA), and 16-32% were flaring at the second visit. Agreement of flare status was low-strong (κ's 0.17-0.88) and inversely related to RA disease activity level. Flare domains correlated highly (r's≥0.70) with each other, patient global (r's≥0.66) and corresponding measures (r's 0.49-0.92); and moderately highly with MD and patient-reported joint counts (r's 0.29-0.62). When MD/patients agreed the patient was flaring, mean flare domain between-group differences were 2.1-3.0; 36% had treatment reductions prior to flare, with escalation planned in 61%. Conclusions: Flares are common in rheumatoid arthritis (RA) and are often preceded by treatment reductions. Patient/MD/DAS agreement of flare status is highest in patients worsening from R/LDA. OMERACT RA flare questions can discriminate between patients with/without flare and have strong evidence of construct and consequential validity. Ongoing work will identify optimal scoring and cut points to identify RA flares

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common cause of severe community-acquired and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease recurrence, or death, by enhancing early S aureus killing, sterilising infected foci and blood faster, and reducing risks of dissemination and metastatic infection. METHODS: In this multicentre, randomised, double-blind, placebo-controlled trial, adults (≥18 years) with S aureus bacteraemia who had received ≤96 h of active antibiotic therapy were recruited from 29 UK hospitals. Patients were randomly assigned (1:1) via a computer-generated sequential randomisation list to receive 2 weeks of adjunctive rifampicin (600 mg or 900 mg per day according to weight, oral or intravenous) versus identical placebo, together with standard antibiotic therapy. Randomisation was stratified by centre. Patients, investigators, and those caring for the patients were masked to group allocation. The primary outcome was time to bacteriologically confirmed treatment failure or disease recurrence, or death (all-cause), from randomisation to 12 weeks, adjudicated by an independent review committee masked to the treatment. Analysis was intention to treat. This trial was registered, number ISRCTN37666216, and is closed to new participants. FINDINGS: Between Dec 10, 2012, and Oct 25, 2016, 758 eligible participants were randomly assigned: 370 to rifampicin and 388 to placebo. 485 (64%) participants had community-acquired S aureus infections, and 132 (17%) had nosocomial S aureus infections. 47 (6%) had meticillin-resistant infections. 301 (40%) participants had an initial deep infection focus. Standard antibiotics were given for 29 (IQR 18-45) days; 619 (82%) participants received flucloxacillin. By week 12, 62 (17%) of participants who received rifampicin versus 71 (18%) who received placebo experienced treatment failure or disease recurrence, or died (absolute risk difference -1·4%, 95% CI -7·0 to 4·3; hazard ratio 0·96, 0·68-1·35, p=0·81). From randomisation to 12 weeks, no evidence of differences in serious (p=0·17) or grade 3-4 (p=0·36) adverse events were observed; however, 63 (17%) participants in the rifampicin group versus 39 (10%) in the placebo group had antibiotic or trial drug-modifying adverse events (p=0·004), and 24 (6%) versus six (2%) had drug interactions (p=0·0005). INTERPRETATION: Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia. FUNDING: UK National Institute for Health Research Health Technology Assessment